SCHEMBL21325060

SCHEMBL21325060

CC(C)(C)c1cnnc2c(OCC3CC3)c(F)ccc12

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALOX5AP P20292 4/20 0.33
▸ FEN1 P39748 4/20 0.33
▸ HTR2C P28335 2/20 0.32
▸ HTR7 P34969 2/20 0.32
▸ HTR2B P41595 2/20 0.32
▸ HTR3A P46098 2/20 0.32
▸ HTR4 Q13639 2/20 0.32
▸ RIPK1 Q13546 1/20 0.32
▸ CYP11B1 P15538 1/20 0.31
▸ CYP11B2 P19099 1/20 0.31
▸ LRRK2 Q5S007 1/20 0.31
▸ TLR9 Q9NR96 1/20 0.31
▸ TLR8 Q9NR97 1/20 0.31
▸ TLR7 Q9NYK1 1/20 0.31
▸ RBP4 P02753 2/20 0.30
▸ HTR1A P08908 1/20 0.30
▸ TTR P02766 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21325050 0.82 HTR2B (0.35) ALOX5APFEN1HTR2CHTR7HTR2B
SCHEMBL21690529 0.81 ALOX5AP (0.34) ALOX5APFEN1HTR2CHTR7HTR2B
SCHEMBL21325058 0.80 FFAR4 (0.35) ALOX5APFEN1RIPK1
SCHEMBL21325056 0.79 ALOX5AP (0.34) ALOX5APFEN1RIPK1CYP11B1CYP11B2
SCHEMBL21325055 0.75 RIPK1 (0.33) ALOX5APFEN1HTR2CHTR7HTR2B
SCHEMBL21325057 0.74 RIPK1 (0.37) ALOX5APFEN1HTR2CHTR7HTR2B
SCHEMBL20202029 0.72 RIPK1 (0.33) ALOX5APFEN1RIPK1
SCHEMBL21325503 0.71 FFAR4 (0.33) ALOX5APFEN1HTR2CHTR2BHTR3A
SCHEMBL20202028 0.70 PIK3R1 (0.39) ALOX5APFEN1HTR2CHTR7HTR2B
SCHEMBL21534011 0.68 HTR2C (0.36) ALOX5APFEN1HTR2CHTR7HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11174271-B2 6-membered uracil isosteres CV6 THERAPEUTICS (NI) LIMITED (GB) 2021-11-16 — — US disclosed
US-11168059-B2 Amino sulfonyl compounds CV6 THERAPEUTICS (NI) LIMITED (GB) 2021-11-09 — — US disclosed
US-10858344-B2 Hydantoin containing deoxyuridine triphosphatase inhibitors CV6 THERAPEUTICS (NI) LIMITED (GB) 2020-12-08 — — US disclosed
US-20190330210-A1 HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS CV6 THERAPEUTICS (NI) LIMITED (GB) 2019-10-31 — — US disclosed
US-20190330158-A1 AMINO SULFONYL COMPOUNDS CV6 THERAPEUTICS (NI) LIMITED (GB) 2019-10-31 — — US disclosed
US-20190270756-A1 6-MEMBERED URACIL ISOSTERES CV6 THERAPEUTICS (NI) LIMITED (GB) 2019-09-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174271-B2 6-membered uracil isosteres UNG, DUT, DPYD ALOX5AP 3330/4885FEN1 52/4885HTR2C 4016/4885
US-20190330210-A1 HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS DUT, TYMP, DPYD ALOX5AP 2919/4885FEN1 108/4885HTR2C 2804/4885
US-10858344-B2 Hydantoin containing deoxyuridine triphosphatase inhibitors DUT, TYMP, DPYD ALOX5AP 2919/4885FEN1 108/4885HTR2C 2804/4885
US-11168059-B2 Amino sulfonyl compounds DPYD, DNPEP, DUT ALOX5AP 4132/4885FEN1 256/4885HTR2C 3286/4885
US-20190330158-A1 AMINO SULFONYL COMPOUNDS DPYD, DNPEP, DUT ALOX5AP 4132/4885FEN1 256/4885HTR2C 3286/4885
US-20190270756-A1 6-MEMBERED URACIL ISOSTERES UNG, DUT, DPYD ALOX5AP 3330/4885FEN1 52/4885HTR2C 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback